<DOC>
	<DOC>NCT00903578</DOC>
	<brief_summary>The present study will examine whether serum FGF-23 and serum phosphate at baseline of kidney transplant recipients can predict progression of allograft dysfunction at 3 years and all-cause mortality at 5 years.</brief_summary>
	<brief_title>Impact of Fibroblast Growth Factor 23 (FGF-23) and Serum Phosphate on Allograft Function and Mortality in Kidney Allograft Recipients</brief_title>
	<detailed_description />
	<criteria>at least one year posttransplantation no more than 10% increase in serum creatinine for the past 3 months refuse to participate in the study any acute illnesses</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>FGF-23</keyword>
	<keyword>vitamin D</keyword>
	<keyword>phosphate</keyword>
	<keyword>allograft dysfunction</keyword>
	<keyword>mortality</keyword>
</DOC>